Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PT MSIG Life Insurance Indonesia Tbk (LIFE.JK)
Jakarta, JK, ID
PT MSIG Life Insurance Indonesia Tbk provides life insurance products in Indonesia. The company operates through six segments: Term Insurance, Endowment, Whole Life Insurance, and Health Insurance. It offers personal accident, medical, and medika ultimax; protection and unit link life insurance; and life insurance, such as smart life guard, smile berkat, income protection x-tra, bank sinarmas, bank bukopin, smile dana sejahtera, and smile pro infinite insurance products. The company also provides group insurance; education and pension insurance; and Sharia Insurance, as well as bancassurance products. It serves individual and group customers. The company was formerly known as PT Asuransi Jiwa Sinarmas MSIG Tbk and changed its name to PT MSIG Life Insurance Indonesia Tbk in July 2023. PT MSIG Life Insurance Indonesia Tbk was founded in 1984 and is based in Setiabudi, Indonesia. PT MSIG Life Insurance Indonesia Tbk operates as a subsidiary of Mitsui Sumitomo Insurance Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.61% | -4.00% | -18.09% | -20.53% | -29.41% | -23.57% | -1.64% | -2.44% | +17.65% | -0.83% | -0.83% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Insurance - Life: +10.6%-16.4% Q1'26: -29.1% (vs Q1'25)
-
EPS growth Insurance - Life: +13.4%-41.3% Q1'26: +486.3% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Life: +31.7%+6.6% Q1'26: +15.6% (vs Q1'25)
-
EBIT margin Insurance - Life: +12.4%+6.6% Q1'26: +13.3% (vs Q1'25)
-
ROIC Insurance - Life: +1.0%+2.7% ★ Q1'26: -44.4% (vs Q1'25)
-
Share dilution Insurance - Life: +0.4%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×0.07× ★ Q1'26: 0.04× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-26 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-25 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-22 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-21 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-20 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-05 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-04 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 2/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 2/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 2/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 2/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-15 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Andrew Bain | Chief Operating & IT Officer | — | male |
| Hadi Setiawan | Head of Investment | — | male |
| Herman Sulistyo | Chief Agency, Corporate & Sharia Business Officer and Director | — | male |
| Lukman Auliadi | Chief Customer & Marketing Office | — | male |
| Novelita Siregar | Chief Human Capital Officer | — | — |
| Renova Siregar | Chief Compliance, Legal, & Corporate Secretary | — | male |
| Satoshi Shiratani | Chief Financial Officer | — | male |
| Tomoyuki Monden | Chief Risk Officer & Vice President Director | — | male |
| Wianto Chen | President Director | — | male |
| Wirawan Damanik Furqon | Head of Finance & Accounting | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LIFE.JK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
